ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 6, 2002

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

Hew Proposes New Rules For Pregnant Women, Fetuses, Prisoners In Research

August 30, 1974

Evidence Supports Screening Younger Women, Expert Says

September 24, 1993

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

Key Hearings Scheduled On Cancer Act, Appropriations

January 21, 1977